We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Handheld Ultrasound Scanners Receive Market Clearance

By MedImaging International staff writers
Posted on 21 May 2013
Image: The Signos RT/Sonimage P3 device (Photo courtesy of Signostics).
Image: The Signos RT/Sonimage P3 device (Photo courtesy of Signostics).
Novel handheld ultrasound scanners features include patented technology and an award-winning design to provide a lightweight, handheld ultrasound device for high-quality imaging at the point-of-care for healthcare professionals, medical practitioners, and veterinarians worldwide across a wide range of clinical settings.

Handheld ultrasound device manufacturer Signostics (Thebarton, SA, Australia) has received a key boost with 510K clearance from the US Food and Drug Administration (FDA) to market its new Signos RT to the American market.

510(k) clearance from the FDA means the Signos RT can now be marketed throughout the US where it will be marketed as the Sonimage P—the brand name of Signostics’ newly appointed global partner Konica Minolta, Inc. (Tokyo, Japan).

“FDA clearance for the USA market further enhances the potential of this innovative product and will enable medical practitioners and patients throughout America to benefit from the real-time point-of-care imaging capabilities that the device provides,” said Signostics’ chief executive officer Warren Ortmann. “This clearance will help us build on the enormous interest we have already received from potential distribution partners throughout Europe, South East Asia, and our own Australian market who have seen and experienced the device first-hand. It certainly is a very important and exciting milestone for Signostics and is a fantastic boost for our new distribution partnership with Konica Minolta.”

The Signos RT/Sonimage P3 device features innovative patented technology and an award-winning design to provide a lightweight, handheld ultrasound device for high quality imaging at the point-of-care for medical practitioners, healthcare professionals, and veterinarians globally across a wide range of clinical settings.

Earlier in 2013, Signostics and Konica Minolta reported a major distribution partnership that sees Konica Minolta marketing the Signos RT/Sonimage P3 device exclusively through Japan, India, China, and the United States.

Related Links:

Signostics


Multi-Use Ultrasound Table
Clinton
X-Ray Generator
Advantage Plus Generators
Half Apron
Demi
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro

Channels

General/Advanced Imaging

view channel
CT and fused SPECT-CT images L to R of representative healthy control, pulmonary fibrosis participant & hypersensitivity pneumonitis participant (Image courtesy of SNMMI)

New SPECT/CT Method Differentiates Inflammation from Fibrosis in Interstitial Lung Disease

Interstitial lung disease (ILD) encompasses more than 200 disorders that inflame or scar the lung interstitium and can lead to progressive respiratory failure. Determining whether active inflammation is... Read more

Imaging IT

view channel
Image: Researchers develop a vision-language model trained on large-scale data to generate clinically relevant findings from chest computed tomography images through visual question answering (Ms. Maiko Nagao from Meijo University, Japan)

Interactive AI Tool Supports Explainable Lung Nodule Assessment

Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.